Gene · 1856
Papers1,699
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,699
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The pros and cons of ubiquitination on the formation of protein condensates. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37294105 | PubTator, text mining | PubMed |
| APEX2-Mediated Proximity Labeling of Wnt Receptor Interactors Upon Pathway Activation. | MicroPubl Biol | 2023 | 37260921 | PubTator, text mining | PubMed |
| Dishevelled segment polarity protein 2 promotes gastric cancer progression through Wnt/β-catenin pathway. | Tissue Cell | 2023 | 37257286 | PubTator, text mining | PubMed |
| Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment. | Front Cell Dev Biol | 2023 | 37255594 | PubTator, text mining | PubMed |
| The Role of Krüppel-like Factors in Pancreatic Physiology and Pathophysiology. | Int J Mol Sci | 2023 | 37239940 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer. | Genes Dis | 2023 | 37223530 | PubTator, text mining | PubMed |
| Relationship between villous atrophy and Wnt pathway gene expressions in pediatric celiac patients. | Rev Assoc Med Bras (1992) | 2023 | 37222325 | PubTator, text mining | PubMed |
| Non-cell-autonomous regulation of interneuron specification mediated by extracellular vesicles. | Sci Adv | 2023 | 37205765 | PubTator, text mining | PubMed |
| Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37190239 | PubTator, text mining | PubMed |
| Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. | Cells | 2023 | 37190050 | PubTator, text mining | PubMed |
| FOXK1 regulates malignant progression and radiosensitivity through direct transcriptional activation of CDC25A and CDK4 in esophageal squamous cell carcinoma. | Sci Rep | 2023 | 37173384 | PubTator, text mining | PubMed |
| Vangl-dependent Wnt/planar cell polarity signaling mediates collective breast carcinoma motility and distant metastasis. | Breast Cancer Res | 2023 | 37147680 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of Lung Cancer. | Curr Pharm Des | 2023 | 37138492 | PubTator, text mining | PubMed |
| Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia. | Front Oncol | 2023 | 37091144 | PubTator, text mining | PubMed |
| Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. | J Exp Clin Cancer Res | 2023 | 37060016 | PubTator, text mining | PubMed |
| Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation. | JCI Insight | 2023 | 37053013 | PubTator, text mining | PubMed |
| Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment. | Int J Mol Sci | 2023 | 37047705 | PubTator, text mining | PubMed |
G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells. | ACS Omega | 2023 | 37033791 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets. | Clin Proteomics | 2023 | 37031178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1856/papers?page=8